{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T09:27:51Z","timestamp":1774171671647,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.seizure.2022.10.022","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T02:57:37Z","timestamp":1667185057000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["EEG-Findings during long-term treatment with everolimus in TSC-associated and therapy-resistant epilepsies in children"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6244-2195","authenticated-orcid":false,"given":"Gert","family":"Wiegand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natia","family":"Japaridze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Gr\u00f6ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0493-7522","authenticated-orcid":false,"given":"Ulrich","family":"Stephani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1548-8216","authenticated-orcid":false,"given":"Navah E.","family":"Kadish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2022.10.022_bib0001","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1469-8749.1964.tb02774.x","article-title":"Tuberose Sclerosis in children: an EEG study","volume":"6","author":"Della Rovere","year":"1964","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2022.10.022_bib0002","unstructured":"Pampiglione, G., Evans, P.R., Harris, R., and Moynahan E.J. (1968) Aspetti elettroclinici della Sclerosi Tuberosa. Atti delle Conferenze di aggiornamento Societd Italiana EEG:pp. 73\u201385."},{"key":"10.1016\/j.seizure.2022.10.022_bib0003","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/jnnp.39.7.666","article-title":"The tuberous sclerosis syndrome: clinical and EEG studies in 100 children","volume":"39","author":"Pampiglione","year":"1976","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.seizure.2022.10.022_bib0004","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1528-1167.2011.03280.x","article-title":"Inhibition of the mammalian target of rapamycin blocks epilepsy progression in NS-Pten conditional knockout mice","volume":"52","author":"Sunnen","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.10.022_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1242\/dmm.002386","article-title":"Rapamycin suppresses seizures and neuronal hypertrophy in a mouse model of cortical dysplasia","volume":"2","author":"Ljungberg","year":"2009","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.seizure.2022.10.022_bib0006","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1212\/WNL.0000000000003400","article-title":"Long-term treatment of epilepsy with everolimus in tuberous sclerosis","volume":"87","author":"Krueger","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2022.10.022_bib0007","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ejpn.2013.06.002","article-title":"Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?","volume":"17","author":"Wiegand","year":"2013","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.seizure.2022.10.022_bib0008","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.seizure.2022.10.022_bib0009","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.seizure.2021.10.011","article-title":"Long-term treatment with everolimus in TSC-associated therapy-resistant epilepsies","volume":"93","author":"Wiegand","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2022.10.022_bib0010","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.seizure.2022.10.022_bib0011","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2022.10.022_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107182","article-title":"Developmental outcomes in children\/adolescents and one adult with tuberous sclerosis complex (TSC) and refractory epilepsy treated with everolimus","volume":"111","author":"Kadish","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2022.10.022_bib0013","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1177\/088307389801301206","article-title":"Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria","volume":"13","author":"Roach","year":"1998","journal-title":"J Child Neurol"},{"key":"10.1016\/j.seizure.2022.10.022_bib0014","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2004.08.084","article-title":"Treatment of interictal epileptiform discharges can improve behavior in children with behavioral problems and epilepsy","volume":"146","author":"Pressler","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.seizure.2022.10.022_bib0015","unstructured":"Reuner G., Rosenkranz J., Bayley N. (eds) (2014) Bayley scales of infant and toddler development: Bayley-III, 3. ed., dt. Fassung. Always learning. Pearson, Frankfurt am Main."},{"key":"10.1016\/j.seizure.2022.10.022_bib0016","doi-asserted-by":"crossref","unstructured":"Sparrow S.S., Cicchetti D.V., Balla D.A. . (2005) Vineland Adaptive Behavior Scales - II. 2nd ed. NCS Pearson Inc, Minneapolis.","DOI":"10.1037\/t15164-000"},{"key":"10.1016\/j.seizure.2022.10.022_bib0017","unstructured":"StataCorp (2013). Stata Statistical Software: release 13. College Station, TX: StataCorp LP."},{"key":"10.1016\/j.seizure.2022.10.022_bib0018","unstructured":"Krueger Darcy A., Care Marguerite M., Holland Katherine et\u00a0al. Everolimus for Subependymal Giant-Cell Astrocytomas in Tuberous Sclerosis."},{"key":"10.1016\/j.seizure.2022.10.022_bib0019","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1212\/WNL.0b013e3182815428","article-title":"Everolimus long-term safety and efficacy in subependymal giant cell astrocytoma","volume":"80","author":"Krueger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2022.10.022_bib0020","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.yebeh.2012.04.128","article-title":"Seizure diaries for clinical research and practice: limitations and future prospects","volume":"24","author":"Fisher","year":"2012","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2022.10.022_bib0021","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24523","article-title":"Everolimus for subependymal giant cell astrocytoma: 5-year final analysis","volume":"78","author":"Franz","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2022.10.022_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuropharm.2012.11.003","article-title":"Behavioural and EEG effects of chronic rapamycin treatment in a mouse model of tuberous sclerosis complex","volume":"67","author":"Cambiaghi","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.seizure.2022.10.022_bib0023","doi-asserted-by":"crossref","first-page":"e57808","DOI":"10.1371\/journal.pone.0057808","article-title":"Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage","volume":"8","author":"Brewster","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.seizure.2022.10.022_bib0024","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/epi.16892","article-title":"Early epileptiform EEG activity in infants with tuberous sclerosis complex predicts epilepsy and neurodevelopmental outcomes","volume":"62","author":"de","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.10.022_bib0025","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/dmcn.13233","article-title":"Immediate termination of electrical status epilepticus in sleep after hemispherotomy is associated with significant progress in language development","volume":"59","author":"Gr\u00f6ppel","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2022.10.022_bib0026","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/epi.16362","article-title":"Generalized quasiperiodic epileptiform activity in sleep is associated with cognitive impairment in children with drug-resistant focal lesional epilepsy","volume":"60","author":"Novak","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.10.022_bib0027","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.yebeh.2010.12.047","article-title":"A role for sleep disruption in cognitive impairment in children with epilepsy","volume":"20","author":"Chan","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2022.10.022_bib0028","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/epi.16823","article-title":"Accelerated long-term forgetting in focal epilepsy: do interictal spikes during sleep matter?","volume":"62","author":"Lambert","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2022.10.022_bib0029","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1212\/WNL.0b013e3182104347","article-title":"Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex","volume":"76","author":"Numis","year":"2011","journal-title":"Neurology"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122002539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131122002539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:01:37Z","timestamp":1761012097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131122002539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"alternative-id":["S1059131122002539"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2022.10.022","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EEG-Findings during long-term treatment with everolimus in TSC-associated and therapy-resistant epilepsies in children","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2022.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 British Epilepsy Association. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}